Literature DB >> 16868519

Comparison of growth patterns of acoustic neuromas with and without radiosurgery.

Alex Battaglia1, Bill Mastrodimos, Roberto Cueva.   

Abstract

OBJECTIVE: To compare the natural history of acoustic neuroma growth to the reported growth rate of acoustic neuromas after radiosurgical therapy, a retrospective review and meta-analysis of the literature was performed. The retrospective review was of one hundred eleven patients (average age, 71 yr) who chose to have their acoustic neuromas managed conservatively in our institution. These patients underwent serial magnetic resonance imaging for assessment of tumor growth for an average period of 38 months. Growth patterns if these untreated tumors were compared to that of radiosurgically treated acoustic neuromas reported in the literature. DATA SOURCES: The English-language literature on the topic was searched systematically by Medline and Pubmed using the following key words: acoustic neuroma, vestibular schwannoma, conservative management, conservative treatment, nonsurgical, age, elderly, growth, observation, untreated, radio-surgery, gamma knife, 13 Gy and 12 Gy. There were no limits to the year of publication. STUDY SELECTION: Articles that fulfilled inclusion criteria (methods) were studied in detail. DATA EXTRACTION: All the articles described in the study selection were used in the review.
CONCLUSION: The average growth rate of the untreated tumors was 0.7 +/- 1.4 mm/yr. Eighty-two percent grew less than 1 mm/yr, whereas 18% grew equal to or more than 1 mm/yr. Thirteen percent grew more than 2 mm/yr, with growth being noted at an average of 2.2 years after diagnosis. This represents an 87% control rate if tumor control rate is defined as less than 2-mm growth/yr. Meta-analysis indicates that tumor control rates range in the radiosurgical literature from 86% to 100%. The mean follow-up periods in the radiosurgical literature are generally not reported. Tumor control is not uniformly defined. Based on the results of this study, there is no discernable significant difference between growth patterns of untreated acoustic neuromas and those treated radiosurgically. To establish a significant difference, longer-term follow-up studies with larger sample sizes and tumor control rates are needed. Tumor control should be defined as zero growth.

Entities:  

Mesh:

Year:  2006        PMID: 16868519     DOI: 10.1097/01.mao.0000226302.59198.87

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  24 in total

1.  Hearing Preservation in Vestibular Schwannoma Surgery.

Authors:  Joe Saliba; Rick A Friedman; Roberto A Cueva
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-10

2.  Hearing in static unilateral vestibular schwannoma declines more than in the contralateral ear.

Authors:  Neel B Patel; Carrie L Nieman; Miriam Redleaf
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-01-13       Impact factor: 1.547

3.  Gamma Knife radiosurgery for vestibular schwannoma: case report and review of the literature.

Authors:  Benjamin J Arthurs; Wayne T Lamoreaux; Neil A Giddings; Robert K Fairbanks; Alexander R Mackay; John J Demakas; Barton S Cooke; Christopher M Lee
Journal:  World J Surg Oncol       Date:  2009-12-18       Impact factor: 2.754

4.  Expectant management of vestibular schwannoma: a retrospective multivariate analysis of tumor growth and outcome.

Authors:  Mark Hughes; Christopher Skilbeck; Shakeel Saeed; Robert Bradford
Journal:  Skull Base       Date:  2011-09

5.  Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease.

Authors:  Susan C Pannullo; Justin F Fraser; Jennifer Moliterno; William Cobb; Philip E Stieg
Journal:  J Neurooncol       Date:  2010-12-09       Impact factor: 4.130

6.  Single Institutional Experience With Observing 564 Vestibular Schwannomas: Factors Associated With Tumor Growth.

Authors:  Jacob B Hunter; David O Francis; Brendan P O'Connell; Edmond K Kabagambe; Marc L Bennett; George B Wanna; Alejandro Rivas; Reid C Thompson; David S Haynes
Journal:  Otol Neurotol       Date:  2016-12       Impact factor: 2.311

Review 7.  What is the Required Frequency of MRI Scanning in the Wait and Scan Management?

Authors:  Thomas Somers; Romain Kania; Jerome Waterval; Tony Van Havenbergh
Journal:  J Int Adv Otol       Date:  2018-04       Impact factor: 1.017

8.  EAONO position statement on Vestibular Schwannoma: Imaging Assessment Question: How should growth of Vestibular Schwannoma be defined?

Authors:  Romain Kania; Benjamin Vérillaud; Domitille Camous; Charlotte Hautefort; Thomas Somers; Jérôme Waterval; Sébastien Froelich; Philippe Herman
Journal:  J Int Adv Otol       Date:  2018-04       Impact factor: 1.017

Review 9.  Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authors:  Scott R Plotkin; Chris Halpin; Jaishri O Blakeley; William H Slattery; D Bradley Welling; Susan M Chang; Jay S Loeffler; Gordon J Harris; A Gregory Sorensen; Michael J McKenna; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

10.  The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.

Authors:  J Jason Clark; Matthew Provenzano; Henry R Diggelmann; Ningyong Xu; Skylar S Hansen; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2008-09       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.